BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1102@pharmaconomics
DTSTAMP:20260707T021626Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:RNAC Phase 3 — Descartes-08 (estimated date)
DESCRIPTION:Phase 3 trial results for Descartes-08 in myasthenia gravis are due ~ Jan 1\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000087/pressrelease05262026.htm\n\nTrack it: https://pharmaconomics.com/e/1102
URL:https://pharmaconomics.com/e/1102
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:RNAC catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR